Profile data is unavailable for this security.
About the company
AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. It has launched tetrahydrocannabinol and cannabidiol (THC/CBD) powder-based hard-shell capsules, based on the Company’s Neuvis platform, for the treatment of pain and related indications. Its products include CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways.
- Revenue in AUD (TTM)2.05m
- Net income in AUD-9.44m
- Incorporated1986
- Employees27.00
- LocationAuscann Group Holdings LtdWangaraPO Box 1746PERTH 6947AustraliaAUS
- Phone+61 86305-0705
- Fax+61 39909-7585
- Websitehttps://auscann.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patrys Ltd | 1.70m | -5.12m | 14.40m | 15.00 | -- | 2.87 | -- | 8.50 | -0.0025 | -0.0025 | 0.0008 | 0.0024 | 0.1978 | -- | 0.5828 | -- | -59.77 | -43.96 | -68.99 | -47.06 | -- | -- | -302.26 | -230.44 | -- | -- | 0.00 | -- | -14.45 | 40.52 | -4.15 | -- | -- | -- |
| BTC Health Ltd | 16.03k | -8.26m | 14.59m | 1.00 | -- | 2.69 | 8.84 | 909.89 | -0.0305 | -0.0305 | 0.00005 | 0.0167 | 0.0017 | -- | 0.031 | -- | -89.67 | -23.15 | -91.36 | -24.64 | -- | -- | -51,522.02 | -2,498.18 | -- | -0.0787 | 0.00 | -- | -86.04 | -26.76 | -1,665.01 | -- | -- | -- |
| Medlab Clinical Ltd | 943.67k | -6.78m | 15.07m | 14.00 | -- | -- | -- | 15.97 | -2.97 | -2.97 | 0.4133 | 0.5604 | 0.1301 | 2.25 | 10.35 | -- | -88.67 | -55.07 | -127.20 | -69.75 | 90.45 | 52.86 | -681.73 | -335.43 | 1.67 | -217.55 | 0.00 | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| Amplia Therapeutics Ltd | 1.87m | -4.46m | 16.43m | 1.00 | -- | 0.8186 | -- | 8.79 | -0.0224 | -0.0224 | 0.0094 | 0.0739 | 0.0949 | -- | 0.7018 | -- | -22.64 | -25.27 | -26.24 | -26.78 | -- | -- | -238.69 | -342.26 | -- | -- | 0.1318 | -- | -42.10 | 12.31 | -71.30 | -- | 31.88 | -- |
| Oncosil Medical Ltd | 355.30k | -11.71m | 16.59m | 2.00 | -- | 2.56 | -- | 46.68 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
| Argent BioPharma Ltd | 1.32m | -17.02m | 16.98m | -- | -- | 10.09 | -- | 12.82 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
| Auscann Group Holdings Ltd | 2.05m | -9.44m | 17.60m | 27.00 | -- | -- | -- | 8.59 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
| Radiopharm Theranostics Ltd | 0.00 | -46.82m | 17.85m | -- | -- | 0.6057 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
| Acrux Ltd | 14.46m | -709.00k | 18.02m | 43.00 | -- | 3.19 | -- | 1.25 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
| Rhythm Biosciences Ltd | 157.67k | -8.63m | 18.64m | -- | -- | 13.63 | -- | 118.25 | -0.0386 | -0.0386 | 0.0007 | 0.0055 | 0.0263 | -- | 1.81 | -- | -144.00 | -106.11 | -169.71 | -125.51 | -1,899.74 | -1,210.71 | -5,473.20 | -6,642.26 | 2.04 | -- | 0.0304 | -- | 814.18 | 28.77 | 6.55 | -- | -20.43 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 18.84m | -- | -- | 1.15 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| Algorae Pharmaceuticals Ltd | 84.10k | -2.25m | 19.40m | -- | -- | 5.36 | -- | 230.73 | -0.0015 | -0.0015 | 0.00006 | 0.0022 | 0.0245 | -- | 1.79 | -- | -65.51 | -46.12 | -70.91 | -53.52 | -- | -- | -2,678.04 | -591.05 | -- | -136.75 | 0.00 | -- | 1,132.26 | -44.06 | -7.68 | -- | -- | -- |
| Syntara Ltd | 9.83m | -14.26m | 20.30m | 107.00 | -- | 2.25 | -- | 2.07 | -0.0197 | -0.0172 | 0.0136 | 0.0075 | 0.442 | 1.58 | 2.22 | -- | -64.13 | -27.33 | -97.76 | -34.23 | 81.69 | 88.37 | -145.11 | -61.99 | 1.75 | -262.59 | 0.0674 | -- | 23.60 | -18.30 | -486.78 | -- | -31.06 | -- |
| Immuron Ltd | 3.58m | -3.88m | 20.75m | 6.00 | -- | 1.18 | -- | 5.80 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
| LBT Innovations Limited | 2.00m | -21.38m | 21.45m | 17.00 | -- | 7.90 | -- | 10.70 | -0.0428 | -0.0428 | 0.0038 | 0.002 | 0.1087 | 0.0819 | 2.25 | 117,882.40 | -115.89 | -28.85 | -131.86 | -30.99 | 94.76 | -- | -1,066.62 | -441.76 | 3.30 | -6.85 | 0.5633 | -- | -5.29 | -18.45 | -239.17 | -- | -34.63 | -- |
| BPH Energy Ltd | 345.67k | 894.65k | 21.95m | 2.00k | 20.41 | 0.9868 | -- | 63.50 | 0.001 | 0.001 | 0.0004 | 0.0203 | 0.0177 | -- | 5.97 | -- | 4.58 | -6.89 | 4.78 | -7.72 | 56.39 | -- | 258.50 | -357.76 | -- | -- | 0.0043 | -- | 96.54 | 5.21 | 179.13 | -- | -- | -- |
Data as of Aug 31 2022. Currency figures normalised to Auscann Group Holdings Ltd's reporting currency: Australian Dollar AUD
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| 1st Capital Management Group GmbHas of 28 Mar 2024 | 0.00 | 0.00% |
Data from 28 Mar 2024 - 28 Mar 2024Source: FactSet Research Systems Inc.
